Senior officials quit from Enron India
Mumbai: More people are leaving Enron India, the Indian subsidiary of the Fortune 500 Enron Corp. Now Ananda Mukherjee, vice-president (global finance), and P Srikumar, vice-president (special projects) — have put in their papers.

This happens as a direct result of the parent company changing track from asset-based projects such as oil fields and pipelines to trading. As a result Enron India has slowed down execution of its two projects — setting up an LNG pipeline in Maharashtra to connect its tank farm in Dabhol, and laying an optic fibre cable network across the country.

The LNG pipeline was being executed by an Enron subsidiary, Metgas, while the optic fibre network was being executed by another subsidiary, Enron Broadband Solutions.

In the past over a dozen employees of Metgas and Enron Broadband Solutions had left the company after Enron decided to keep these projects on the backburner.

Dabhol Power Company, Enron’s only operating company in India in which it holds a 65 per cent stake has not been affected so far. However, Enron has made it clear that it would like to divest a majority stake in the company.
Back to News Review index page  

Ranbaxy inducts new managers
New Delhi: Ranbaxy’s added thrust on the R&D and OTC business is part of the company’s growth strategy to become a $1-billion company by 2004.

Brian Tempest, president (pharmaceuticals worldwide) said the company in line with this the company was strengthening its current senior and middle level management team both through new recruitments and internal promotions.

The company has just roped in Udai Upendra from Colgate Palmolein as the company’s new VP (global HR), Lalith Ahluwalia from Gilette as director (business finance) and Sanjiv Dani from Johnson & Johnson as its new director, marketing in Ranbaxy’s pharma division.

Ranbaxy’s new OTC division will be headed by Atul Malhotra, who has just joined the company from HLL.

Besides this, Ranbaxy has moved its country manager in Vietnam Sugatto Bhattacharya as MD of Ranbaxy UK and Ranbaxy Ireland.
Back to News Review index page